Perinatal and early childhood stroke and thrombophilia

Pathology

Volumn 40, Issue 2, 2008, Pages 116-123

  Mackay, Mark T ^a,b   Monagle, Paul ^a,c,d  

^a Royal Children's Hospital

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Arterial stroke; Cerebral sinovenous thrombosis; Paediatric; Perinatal; Thrombophilia; Vasculopathy

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ANTICOAGULATION; ARTERY DISSECTION; BLOOD CLOT LYSIS; BLOOD CLOTTING; BRAIN EMBOLISM; BRAIN VASCULITIS; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN; IRON DEFICIENCY; MOYAMOYA DISEASE; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERINATAL PERIOD; RECURRENCE RISK; RISK FACTOR; STROKE; THROMBOPHILIA;

EID: 38349068709     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701813768     Document Type: Article

References (94)

1. Murphy SL. Deaths: final data for 1998. Natl Vital Stat Rep 2000; 48: 1-105.
2. deVeber G. The Canadian Pediatric Ischemic Stroke Study Group. Canadian pediatric ischaemic stroke study registry: analysis of children with arterial ischaemic stroke. Ann Neurol 2000; 48: 514 (abstr).
3. Ganesan V, Prengler M, McShane MA, et al. Investigation of risk factors in children with arterial ischemic stroke. (See comment.) Ann Neurol 2003; 53: 167-73.
4. Chabrier S, Husson B, Lasjaunias P, et al. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 2000; 15: 290-4.
5. Kirkham FJ, Prengler M, Hewes DK, et al. Risk factors for arterial ischemic stroke in children. J Child Neurol 2000; 15: 299-307.
6. Williams LS, Garg BP, Cohen M, et al. Subtypes of ischemic stroke in children and young adults. Neurology 1997; 49: 1541-5.
7. Sebire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999; 45: 679-80.
8. Fullerton HJ, Wu YW, Sidney S, et al. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119: 495-501.
9. Sebire G, Fullerton H, Riou E, et al. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr 2004; 16: 617-22.
10. Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001; 32: 1257-62.
11. Berger TM, Caduff JH, Gebbers JO. Fatal varicella-zoster virus antigen-positive giant cell arteritis of the central nervous system. Pediatr Infect Dis J 2000; 19: 653-6.
12. Fullerton HJ, Johnston SC, Smith WS. Arterial dissection and stroke in children. Neurology 2001; 57: 1155-60.
13. Carvalho KS, Edwards-Brown M, Golomb MR. Carotid dissection and stroke after tonsillectomy and adenoidectomy. Pediatr Neurol 2007; 37: 127-9.
14. Rafay MF, Armstrong D, deVeber G, et al. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J Child Neurol 2006; 21: 8-16.
15. Camacho A, Villarejo A, de Aragon AM, et al. Spontaneous carotid and vertebral artery dissection in children. Pediatr Neurol 2001; 25: 250-3.
16. Suzuki J, Kodama N. Moyamoya disease - a review. Stroke 1983; 14: 104-9.
17. Lanthier S, Lortie A, Michaud J, et al. Isolated angiitis of the CNS in children. Neurology 2001; 56: 837-42.
18. Strater R, Becker S, von EA, et al. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. (See comment.) Lancet 2002; 360: 1540-5.
19. Ignjatovic V, Greenway A, Summerhayes R, et al. Thrombin generation: the functional role of alpha-2-macroglobulin and influence of developmental haemostasis. Br J Haematol 2007; 138: 366-8.
20. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
21. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
22. Rosendaal FR. Venous thrombosis: prevalence and interaction of risk factors. Haemostasis 1999; 29 (Suppl S1): 1-9.
23. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
24. Allaart CF, Poort SR, Rosendaal FR, et al. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-8.
25. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
26. Bonduel M, Sciuccati G, Hepner M, et al. Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry. Acta Haematol 2006; 115: 180-5.
27. Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. J Pediatr 1999; 158 (Suppl 3): S97.
28. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 354: 1031.
29. Nowak-Gottl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100: 743-8.
30. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981; 10: 369-90.
31. Nizzi FA Jr, Kaplan HS. Protein C and S deficiency. Semin Thromb Hemost 1999; 25: 265-72.
32. Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7.
33. Dahlback B. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis. Rev Invest Clin 1997; 49 (Suppl 1): 3-5.
34. Orefice G, Ames PR, Coppola M, et al. Antiphospholipid antibodies and cerebrovascular disease. Acta Neurol (Napoli) 1993; 15: 303-10.
35. Bick RL, Baker WF. Antiphospholipid syndrome and thrombosis. Semin Thromb Hemost 1999; 25: 333-50.
36. Espinoza LR, Hartmann RC. Significance of the lupus anticoagulant. Am J Hematol 1986; 22: 331-7.
37. Vinazzer H. Hereditary and acquired antithrombin deficiency. Semin Thromb Hemost 1999; 25: 257-63.
38. al-Hakim M, Katirji B, Osorio I, et al. Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: report of two cases. Neurology 1993; 43: 742-6.
39. Peytremann R, Rhodes RS, Hartmann RC. Thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) with particular reference to progressive, diffuse hepatic venous thrombosis. Ser Haematol 1972; 5: 115-36.
40. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-91.
41. Nguyen P, Reynaud J, Pouzol P, et al. Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children. Eur J Pediatr 1994; 153: 646-9.
42. Ohlin AK, Norlund L, Marlar RA. Thrombomodulin gene variations and thromboembolic disease. Thromb Haemost 1997; 78: 396-400.
43. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000; 109: 519-22.
44. Ehrenforth S, ygoren-Pursun E, Hach-Wunderle V, et al. Prevalence of elevated histidine-rich glycoprotein in patients with thrombophilia - a study of 695 patients. Thromb Haemost 1994; 71: 160-1.
45. Souto JC, Gari M, Falkon L, et al. A new case of hereditary histidine-rich glycoprotein deficiency with familial thrombophilia. Thromb Haemost 1996; 75: 374-5.
46. Demarmels BF, Sulzer I, Stucki B, et al. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members. Thromb Haemost 1998; 80: 167-70.
47. Lentz SR. Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 1998; 5: 343-9.
48. Makris M. Hyperhomocysteinemia and thrombosis. Clin Lab Haematol 2000; 22: 133-43.
49. Ganesan V, Kirkham FJ. Mechanisms of ischaemic stroke after chickenpox. Arch Dis Child 1997; 76: 522-5.
50. Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 645-87S.
51. Barnes C, deVeber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res 2006; 118: 67-74.
52. Angelini L, Ravelli A, Caporali R, et al. Antiphospholipid antibodies in children with idiopathic cerebral ischaemia. Lancet 1994; 344: 1232.
53. Becker S, Heller C, Gropp F, et al. Thrombophilic disorders in children with cerebral infarction. Lancet 1998; 352: 1756-7.
54. Bonduel M, Sciuccati G, Hepner M, et al. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol 1999; 56: 967-71.
55. Ganesan V, Kelsey H, Cookson J, et al. Activated protein C resistance in childhood stroke. Lancet 1996; 347: 260.
56. Strater R, Vielhaber H, Kassenbohmer R, et al. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999; 158 (Suppl 3): S122-5.
57. Heller C, Becker S, Scharrer I, et al. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr 1999; 158 (Suppl 3): S117-21.
58. Nowak-Gottl U, Strater R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94: 3678-82.
59. Ganesan V, McShane MA, Liesner R, et al. Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry 1998; 65: 508-11.
60. McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210G->A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999; 81: 690-4.
61. Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost 1998; 80: 763-6.
62. Chan A, Crowther M, deVeber G. Factor V Leiden and arterial ischemic stroke: a metanalysis. Blood 2000; 95 (Suppl 1): 645 (abstr).
63. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31: 1283-8.
64. deVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55: 1539-43.
65. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996; 128: 319-23.
66. Barnes C, Newall F, Chan A, et al. MTHFR mutation in childhood stroke. Blood 2007; 98: 95 (abstr).
67. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5-11.
68. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997; 42: 699-704.
69. Hartfield DS, Lowry NJ, Keene DL, et al. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol 1997; 16: 50-3.
70. Ganesan V, Prengler M, Wade A, et al. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006; 114: 2170-7.
71. Lanthier S, Carmant L, David M, et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54: 371-8.
72. Danchaivijitr N, Cox TC, Saunders DE, et al. Evolution of cerebral arteriopathies in childhood arterial ischemic stroke. Ann Neurol 2006; 59: 620-6.
73. Lanthier S, Kirkham FJ, Mitchell LG, et al. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology 2004; 62: 194-200.
74. Lee J, Croen LA, Lindan C, et al. Predictors of outcome in perinatal arterial stroke: a population-based study. Ann Neurol 2005; 58: 303-8.
75. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol 2004; 3: 150-8.
76. Mercuri E, Rutherford M, Cowan F, et al. Early prognostic indicators of outcome in infants with neonatal cerebral infarction: a clinical, electroencephalogram, and magnetic resonance imaging study. Pediatrics 1999; 103: 39-46.
77. James AH, Tapson VF, Goldhaber SZ, et al. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005; 193: 216-9.
78. Nelson KB. Perinatal ischemic stroke. Stroke 2007; 38 (2 Suppl): 742-5.
79. Mercuri E, Cowan F, Gupte G, et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001; 107: 1400-4.
80. Gunther G, Junker R, Strater R, et al. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors. Stroke 2000; 31: 2437-41.
81. Curry CJ, Bhullar S, Holmes J, et al. Risk factors for perinatal arterial stroke: a study of 60 mother-child pairs. Pediatr Neurol 2007; 37: 99-107.
82. Miller SP, Wu YW, Lee J, et al. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke 2006; 37: 2678-83.
83. Pellicer A, Cabanas F, Garcia-Alix A, et al. Stroke in neonates with cardiac right-to-left shunt. Brain Dev 1992; 14: 381-5.
84. Kurnik K, Kosch A, Strater R, et al. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke 2003; 34: 2887-92.
85. deVeber G. Cerebrovascular diseases in children. In: Swainman KF, Ashwal S, editors. Pediatric Neurology: Principles and Practice. St Louis: Mosby, 1999; 1099-124.
86. Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128: 477-89.
87. deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
88. Wu YW, Miller SP, Chin K, et al. Multiple risk factors in neonatal sinovenous thrombosis. Neurology 2002; 59: 438-40.
89. Kenet G, Waldman D, Lubetsky A, et al. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost 2004; 92: 713-8.
90. Kenet G, Kirkham F, Niederstadt T, et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol 2007; 6: 595-603.
91. Royal College of Physicians. Paediatric Stroke Working Group. Stroke in Childhood; Clinical Guidelines for Diagnosis, Management and Rehabilitation. Suffolk: The Lavenham Press, 2004.
92. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 483-512S.
93. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.
94. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-8.